Entremed, Inc.
Records under this name other than patents Entremed, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,132,138 | Method for the treatment of multiple sclerosis Formerly held In force · USPTO record | In force | USPTO record | |
| US 8,399,440 | Disease modifying anti-arthritic activity of 2-methoxyestradiol Formerly held Lapsed on the fee record Ended Mar 19, 2025 · USPTO record | Lapsed on the fee record | Ended Mar 19, 2025 | USPTO record |
| US 7,078,507 | Synthetic genes for malarial proteins and methods of use Formerly held Term ended Term ended Nov 12, 2022 · USPTO record | Term ended | Term ended Nov 12, 2022 | USPTO record |
| US 7,303,751 | Anti-plasmodium compositions and methods of use Formerly held Term ended Term ended Nov 5, 2022 · USPTO record | Term ended | Term ended Nov 5, 2022 | USPTO record |
| US 7,087,592 | Compositions comprising purified 2-methoxyestradiol and methods of producing same Formerly held Term ended Term ended Mar 12, 2022 · USPTO record | Term ended | Term ended Mar 12, 2022 | USPTO record |
| US 6,723,536 | Method of Producing and Purifying Angiostatin Formerly held Term ended Term ended Dec 4, 2020 · Medium confidence | Term ended | Term ended Dec 4, 2020 | Medium confidence |
| US 7,476,726 | Method of Producing and Purifying Endostatin Protein Formerly held Term ended Term ended Dec 2, 2020 · High confidence | Term ended | Term ended Dec 2, 2020 | High confidence |
| US 7,235,540 | Methods of using 2-methoxyestradiol of high purity Formerly held Term ended Ended no later than Aug 23, 2020 · USPTO record | Term ended | Ended no later than Aug 23, 2020 | USPTO record |
| US 7,025,961 | Anti-plasmodium composition and methods of use Formerly held Term ended Term ended Mar 3, 2020 · USPTO record | Term ended | Term ended Mar 3, 2020 | USPTO record |
| US 7,157,556 | Deglycosylated kringle 1-3 region fragments of plasminogen and methods of use Formerly held Term ended Term ended Feb 10, 2020 · USPTO record | Term ended | Term ended Feb 10, 2020 | USPTO record |